EpiEndo Pharmaceuticals Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series B
  • (Upcoming)

  • Latest Deal Amount
  • $175M

  • Investors
  • 7

EpiEndo Pharmaceuticals General Information

Description

Developer of therapeutics designed to treat chronic respiratory and inflammatory disorders by improving epithelial function and host defense mechanisms. The company offers orally available macrolide-derived compounds with reduced antimicrobial resistance potential and anti-inflammatory properties, enabling patients with chronic respiratory and inflammatory conditions to reduce disease exacerbations and improve immune response to inhaled pathogens.

Contact Information

Website
www.epiendo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kristínargata 1
  • Reykjavik, 102
  • Iceland
+354 454
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Kristínargata 1
  • Reykjavik, 102
  • Iceland
+354 454

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EpiEndo Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Later Stage VC (Series B) $175M Upcoming Clinical Trials - Phase 2
12. Later Stage VC 07-Jan-2026 Completed Clinical Trials - Phase 2
11. Later Stage VC (Series A) 01-Sep-2022 Completed Clinical Trials - Phase 2
10. Later Stage VC 15-Apr-2021 Completed Clinical Trials - Phase 2
9. Seed Round 19-Dec-2019 Completed Clinical Trials - Phase 2
8. Grant 09-Oct-2019 Completed Clinical Trials - Phase 2
7. Seed Round 17-Jan-2019 Completed Clinical Trials - Phase 2
6. Grant 29-Jun-2018 Completed Startup
5. Grant 31-Jan-2017 Completed Startup
4. Seed Round 20-Sep-2016 Completed Startup
To view EpiEndo Pharmaceuticals’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

EpiEndo Pharmaceuticals Patents

EpiEndo Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202416444-D0 Compounds Inactive 07-Nov-2024
GB-202413660-D0 Compounds Inactive 17-Sep-2024
WO-2026041802-A1 Azithromycin derivatives for use in the treatment of infections Pending 23-Aug-2024
GB-202412461-D0 Medial use Inactive 23-Aug-2024
GB-202404587-D0 Chemical forms Inactive 28-Mar-2024 C07H17/08
To view EpiEndo Pharmaceuticals’s complete patent history, request access »

EpiEndo Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EpiEndo Pharmaceuticals Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Flerie Venture Capital Minority
InfoCapital Venture Capital Minority
Kvika Framtak PE/Buyout Minority
Tunga fjárfestingafélag Family Office Minority
European Innovation Council Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

EpiEndo Pharmaceuticals FAQs

  • When was EpiEndo Pharmaceuticals founded?

    EpiEndo Pharmaceuticals was founded in 2014.

  • Where is EpiEndo Pharmaceuticals headquartered?

    EpiEndo Pharmaceuticals is headquartered in Reykjavik, Iceland.

  • What is the size of EpiEndo Pharmaceuticals?

    EpiEndo Pharmaceuticals has 9 total employees.

  • What industry is EpiEndo Pharmaceuticals in?

    EpiEndo Pharmaceuticals’s primary industry is Drug Discovery.

  • Is EpiEndo Pharmaceuticals a private or public company?

    EpiEndo Pharmaceuticals is a Private company.

  • What is EpiEndo Pharmaceuticals’s current revenue?

    The current revenue for EpiEndo Pharmaceuticals is .

  • How much funding has EpiEndo Pharmaceuticals raised over time?

    EpiEndo Pharmaceuticals has raised $37.1M.

  • Who are EpiEndo Pharmaceuticals’s investors?

    Flerie, InfoCapital, Kvika Framtak, Tunga fjárfestingafélag, and European Innovation Council are 5 of 7 investors who have invested in EpiEndo Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process